APA (7th ed.) Citation

Qian, J., & Chu, T. Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report. Elsevier.

Chicago Style (17th ed.) Citation

Qian, Jialin, and Tianqing Chu. Long Term Efficacy and Safety of Lorlatinib in ALK-positive Non-small Cell Lung Cancer: A Case Report. Elsevier.

MLA (9th ed.) Citation

Qian, Jialin, and Tianqing Chu. Long Term Efficacy and Safety of Lorlatinib in ALK-positive Non-small Cell Lung Cancer: A Case Report. Elsevier.

Warning: These citations may not always be 100% accurate.